Advanced Medical Solutions Group plc (AIM: AMS)

Market Cap	427.00M
Revenue (ttm)	131.11M
Net Income (ttm)	11.13M
Shares Out	217.86M
EPS (ttm)	0.05
PE Ratio	38.36
Forward PE	16.55
Dividend	0.02 (1.24%)
Ex-Dividend Date	Sep 26, 2024

Volume	255,764
Open	197.40
Previous Close	191.80
Day's Range	189.40 - 197.40
52-Week Range	176.60 - 275.83
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Dec 17, 2024

About AIM: AMS

Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. It operates in two segments, Surgical and Woundcare. The company offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G brand names. It also provides wound car...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1991
• Employees: 850
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: AMS

Financial Performance

In 2023, AMS's revenue was 126.21 million, an increase of 1.51% compared to the previous year's 124.33 million. Earnings were 15.89 million, a decrease of -22.14%.